Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BERYL DRUGS vs VISTA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BERYL DRUGS VISTA PHARMA BERYL DRUGS/
VISTA PHARMA
 
P/E (TTM) x 51.6 -20.4 - View Chart
P/BV x 1.9 2.3 86.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 BERYL DRUGS   VISTA PHARMA
EQUITY SHARE DATA
    BERYL DRUGS
Mar-24
VISTA PHARMA
Mar-23
BERYL DRUGS/
VISTA PHARMA
5-Yr Chart
Click to enlarge
High Rs4514 312.1%   
Low Rs127 179.0%   
Sales per share (Unadj.) Rs52.70.3 19,723.4%  
Earnings per share (Unadj.) Rs1.5-1.5 -100.6%  
Cash flow per share (Unadj.) Rs3.9-1.3 -289.2%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs17.68.1 216.4%  
Shares outstanding (eoy) m5.0737.56 13.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.539.1 1.4%   
Avg P/E ratio x18.7-6.9 -269.3%  
P/CF ratio (eoy) x7.3-7.8 -93.6%  
Price / Book Value ratio x1.61.3 125.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m144393 36.6%   
No. of employees `000NANA-   
Total wages/salary Rs m175 337.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m26710 2,662.4%  
Other income Rs m54 120.6%   
Total revenues Rs m27214 1,939.5%   
Gross profit Rs m22-44 -49.6%  
Depreciation Rs m126 194.3%   
Interest Rs m512 39.0%   
Profit before tax Rs m10-59 -17.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2-2 -112.6%   
Profit after tax Rs m8-57 -13.6%  
Gross profit margin %8.2-442.7 -1.9%  
Effective tax rate %23.93.6 654.5%   
Net profit margin %2.9-563.9 -0.5%  
BALANCE SHEET DATA
Current assets Rs m105238 44.4%   
Current liabilities Rs m61141 43.2%   
Net working cap to sales %16.7963.0 1.7%  
Current ratio x1.71.7 102.9%  
Inventory Days Days14207 6.6%  
Debtors Days Days1,03640,902 2.5%  
Net fixed assets Rs m72296 24.2%   
Share capital Rs m5175 67.8%   
"Free" reserves Rs m38230 16.6%   
Net worth Rs m89306 29.2%   
Long term debt Rs m2452 46.4%   
Total assets Rs m177534 33.2%  
Interest coverage x3.1-3.8 -81.5%   
Debt to equity ratio x0.30.2 158.9%  
Sales to assets ratio x1.50 8,027.3%   
Return on assets %7.0-8.3 -84.2%  
Return on equity %8.6-18.5 -46.5%  
Return on capital %13.1-13.1 -100.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m8-17 -47.9%  
From Investments Rs m-11-13 85.2%  
From Financial Activity Rs m131 3.3%  
Net Cashflow Rs m-21 -119.7%  

Share Holding

Indian Promoters % 26.4 11.9 221.5%  
Foreign collaborators % 0.0 9.3 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 73.6 78.8 93.4%  
Shareholders   7,364 13,913 52.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BERYL DRUGS With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BERYL DRUGS vs VISTA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BERYL DRUGS vs VISTA PHARMA Share Price Performance

Period BERYL DRUGS VISTA PHARMA S&P BSE HEALTHCARE
1-Day 5.88% 4.41% 0.69%
1-Month -2.29% 0.34% -0.78%
1-Year 72.73% -32.42% 42.85%
3-Year CAGR 48.80% 7.09% 20.14%
5-Year CAGR 46.14% 2.77% 26.11%

* Compound Annual Growth Rate

Here are more details on the BERYL DRUGS share price and the VISTA PHARMA share price.

Moving on to shareholding structures...

The promoters of BERYL DRUGS hold a 26.4% stake in the company. In case of VISTA PHARMA the stake stands at 21.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BERYL DRUGS and the shareholding pattern of VISTA PHARMA.

Finally, a word on dividends...

In the most recent financial year, BERYL DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

VISTA PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of BERYL DRUGS, and the dividend history of VISTA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.